New therapeutic Insights Against Fungal Infections Derived from Crocodiles
DOI:
https://doi.org/10.61173/cs9t1x79Keywords:
CpoBD13, antifungal activity, animal-de-rived, membrane disruptionAbstract
The CpoBD13 is a β-defensin found in saltwater crocodile. This compound has potential applications in antifungal drug development. As part of nature immune system in crocodile, this peptide represents strong antifungal activity against certain pathogen, it can disrupt certain fungal cell membranes specifically. Its unique mechanism, which binds with phospholipids in fungal membranes, destabilize the membranes, and cause cell death eventually, makes it differs from traditional antifungal treatment. This mechanism disrupts fungal physically and therefore largely reduced the resistance issue developed among fungal. With its pH-sensitive nature, CpoBD13 can easily adopted to acidic environments, this allows it to interact with fungal membranes more intensely, also allows it to be more active in infected areas, like injuries on skins. Although some challenges remain in its stability and viability, new therapies against fungal infections can be discovered through this animal-derived peptides. Further study and research are needed to refine the application and production of CpoBD13 in clinical treatment. To better fill this research gap, this paper aims to discover the mechanism, the potential application, and the future expectation of CpoBD13 in clinical use.
References
[1] Guo, F.-W., Zhang, Q., Gu, Y.-C., & Shao, C.-L. (2023). Sulfur-containing marine natural products as leads for drug discovery and development. Current Opinion in Chemical Biology, 75, 102330–102330. https://doi.org/10.1016/ j.cbpa.2023.102330
[2] Depoorter, E., Bull, M. J., Peeters, C., Coenye, T., Vandamme, P., & Mahenthiralingam, E. (2016). Burkholderia: an update on taxonomy and biotechnological potential as antibiotic producers. Applied Microbiology and Biotechnology, 100(12), 5215–5229. https://doi.org/10.1007/s00253-016-7520-x
[3] Ji, S., An, F., Zhang, T., Lou, M., Guo, J., Liu, K., Zhu, Y., Wu, J., & Wu, R. (2024). Antimicrobial peptides: An alternative to traditional antibiotics. European Journal of Medicinal Chemistry, 265, 116072–116072. https://doi.org/10.1016/ j.ejmech.2023.116072
[4] Williams, S. A., Lay, F. T., Bindra, G. K., Banjara, S., Poon, I. K. H., Phan, T. K., Kvansakul, M., & Hulett, M. D. (2023). Crocodile defensin (CpoBD13) antifungal activity via pH- dependent phospholipid targeting and membrane disruption. Nature Communications, 14(1), 1170. https://doi.org/10.1038/ s41467-023-36280-y
[5] Mookherjee, N., Anderson, M. A., Haagsman, H. P., & Davidson, D. J. (2020). Antimicrobial host defence peptides: functions and clinical potential. Nature Reviews Drug Discovery, 19(5), 311–332. https://doi.org/10.1038/s41573-019-0058-8
[6] Phan, T. K., Lay, F. T., Poon, I. K. H., Hinds, M. G., Kvansakul, M., & Hulett, M. D. (2015). Human β-defensin 3 contains an oncolytic motif that binds PI(4,5)P2 to mediate tumour cell permeabilisation. Oncotarget, 7(2), 2054–2069. https://doi.org/10.18632/oncotarget.6520
[7] Santana, F. L., Arenas, I., Haney, E. F., Estrada, K., Hancock, R. E. W., & Corzo, G. (2021). Identification of a crocodylian β-defensin variant from Alligator mississippiensis with antimicrobial and antibiofilm activity. Peptides, 141, 170549. Dean&Francis Zijie Zhang https://doi.org/10.1016/j.peptides.2021.170549
[8] Percival, S. L., McCarty, S., Hunt, J. A., & Woods, E. J. (2014). The effects of pH on wound healing, biofilms, and antimicrobial efficacy. Wound Repair and Regeneration, 22(2), 174–186. https://doi.org/10.1111/wrr.12125
[9] Alaiwa, M. H. A., Reznikov, L. R., Gansemer, N. D., Sheets, K. A., Horswill, A. R., Stoltz, D. A., Zabner, J., & Welsh, M. J. (2014). pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37. Proceedings of the National Academy of Sciences, 111(52), 18703–18708. https://doi.org/10.1073/pnas.1422091112
[10] Nikolinka Antcheva, Morgera, F., Creatti, L., Vaccari, L., Pag, U., Pacor, S., Shai, Y., Sahl, H.-G., & Alessandro Tossi. (2009). Artificial β-defensin based on a minimal defensin template. Biochemical Journal, 421(3), 435–447. https://doi. org/10.1042/bj20082242
[11] Baddley, J. W., & Pappas, P. G. (2005). Antifungal Combination Therapy. Drugs, 65(11), 1461–1480. https://doi. org/10.2165/00003495-200565110-00002
[12] Redwan, el-Rashdy M. (2009). Animal-derived pharmaceutical proteins. Journal of Immunoassay & Immunochemistry, 30(3), 262–290. https://doi. org/10.1080/15321810903084400
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
